Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
We carefully evaluate your medical history, aesthetic objectives, and overall wellness goals to determine if semaglutide treatment is appropriate for you
Medicare Part D Claims for GLP-1s (CY 2018 to 2022) The expanded indication for Wegovy is expected to increase spending on this medication class
Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage
Wegovy is a once-weekly injectable medication whose active ingredient is semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist
If you qualify for a plan currently enrolling trial participants, you can get Wegovy for free or at a steeply discounted price
US$ 26.21
US$ 27.89
US$ 22.32
US$ 21.70
US$ 21.75
US$ 29.31
US$ 21.56
US$ 23.66
US$ 21.25
